Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated plasma total homocysteine (tHcy) is associated with the development of Alzheimer's disease and other forms of dementia. In this study, we report the relationship between tHcy and epigenetic age in older adults with mild cognitive impairment from the VITACOG study. Epigenetic age and ra...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Holmes, HE, Valentin, RE, Jernerén, F, de Jager Loots, CA, Refsum, H, Smith, AD, Guarente, L, Dellinger, RW, Sampson, D, Alzheimer's Disease Neuroimaging Initiative
Format:	Journal article
Język:	English
Wydane:	Wiley Open Access 2024

Podobne zapisy

Random forest prediction of Alzheimer's disease using pairwise selection from time series data
od: Moore, P, i wsp.
Wydane: (2019)

Two for tau: automated model discovery reveals two-stage tau aggregation dynamics in Alzheimer’s disease
od: Stockman, CA, i wsp.
Wydane: (2024)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
od: Oulhaj, A, i wsp.
Wydane: (2016)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
od: de Jager, C, i wsp.
Wydane: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
od: De Jager, C, i wsp.
Wydane: (2012)

Quantifying uncertainty in brain-predicted age using scalar-on-image quantile regression
od: Palma, M, i wsp.
Wydane: (2020)

Elevated homocysteine and N-methyl-d-aspartate-receptor antibodies as a cause of behavioural and cognitive decline in 22q11.2 deletion syndrome.
od: Jones, S, i wsp.
Wydane: (2017)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
od: Smith, A, i wsp.
Wydane: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
od: Smith, A, i wsp.
Wydane: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
od: Smith, A, i wsp.
Wydane: (2010)

Homocysteine, B vitamins, and cognitive impairment
od: Smith, A, i wsp.
Wydane: (2016)

Homocysteine, B vitamins, and cardiovascular disease
od: Refsum, H, i wsp.
Wydane: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
od: Refsum, H, i wsp.
Wydane: (2006)

Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study.
od: Nurk, E, i wsp.
Wydane: (2005)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
od: De Jager, C, i wsp.
Wydane: (2012)

Morphometricity as a measure of the neuroanatomical signature of a trait
od: Ge, Tian, i wsp.
Wydane: (2017)

Disrupted network topology in patients with stable and progressive mild cognitive impairment and Alzheimer's disease
od: Pereira, J, i wsp.
Wydane: (2016)

Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers
od: Nho, K, i wsp.
Wydane: (2018)

Generalized reduced rank latent factor regression for high dimensional tensor fields, and neuroimaging-genetic applications
od: Tao, C, i wsp.
Wydane: (2016)

Accelerating permutation testing in voxel-wise analysis through subspace tracking: A new plugin for SnPM
od: Gutierrez-Barragan, F, i wsp.
Wydane: (2017)

Elevated plasma total homocysteine increased the risk of dementia in the elderly: Commentary
od: Sheehan, B, i wsp.
Wydane: (2002)

Elevated plasma total homocysteine levels increased the risk for dementia in the elderly.
od: Sheehan, B, i wsp.
Wydane: (2002)

The hordaland homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease
od: Refsum, H, i wsp.
Wydane: (2006)

Homocysteine and dementia – an international consensus statement
od: Smith, DA, i wsp.
Wydane: (2018)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
od: Oulhaj, A, i wsp.
Wydane: (2010)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease
od: Oulhaj, A, i wsp.
Wydane: (2010)

Facts and recommendations about total homocysteine determinations: an expert opinion
od: Refsum, H, i wsp.
Wydane: (2004)

Effects of S-adenosyl-L-homocysteine and trichostatin A on developmental competence, epigenetic modification, and gene expression in cloned cattle embryos
od: Jafari, Shahram
Wydane: (2012)

Variability and determinants of total homocysteine concentrations in plasma in an elderly population.
od: Clarke, R, i wsp.
Wydane: (1998)

Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials
od: Clarke, R, i wsp.
Wydane: (2011)

Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.
od: Clarke, R, i wsp.
Wydane: (2011)

Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study.
od: Halsted, C, i wsp.
Wydane: (2007)

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.
od: Clarke, R, i wsp.
Wydane: (1998)

Polymorphisms in the catechol-O-methyltransferase (COMT) gene influence plasma total homocysteine levels.
od: Tunbridge, E, i wsp.
Wydane: (2008)

Sirt3 deficiency does not affect venous thrombosis or NETosis despite mild elevation of intracellular ROS in platelets and neutrophils in mice
od: Hayashi, Hideki, i wsp.
Wydane: (2018)

Facts and recommendations about total homocysteine determinations: an expert opinion.
od: Refsum, H, i wsp.
Wydane: (2004)

Cysteine, homocysteine and bone mineral density: a role for body composition?
od: Elshorbagy, A, i wsp.
Wydane: (2009)

Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
od: Clarke, R, i wsp.
Wydane: (2001)

Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people.
od: Budge, M, i wsp.
Wydane: (2002)

Human plasma homocysteine levels are associated with the catechol-O-methyltransferase Val158Met polymorphism
od: Tunbridge, E, i wsp.
Wydane: (2007)